"At Methodist Estabrook Cancer Center, you can receive care close to home and family in a place where you are treated like the neighbors and friends you are. Our nationally-recognized and accredited treatment center supports southwestern Iowa, southeastern Nebraska, and throughout the Omaha and Council Bluffs metro area."

During the past decade, Methodist Estabrook Cancer Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 87 clinical trials were completed, i.e. on average, 1740% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 15 clinical trials were completed. i.e. 1500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Methodist Estabrook Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 67 trials, followed by "SCRI Development Innovations, LLC" with 28 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored, "NSABP Foundation Inc" with 16 trials sponsored and "SWOG Cancer Research Network" with 16 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Methodist Estabrook Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 135 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Genentech, Inc." with 13 trials as a collaborator, "Eastern Cooperative Oncology Group" with 12 trials as a collaborator and "NCIC Clinical Trials Group" with 11 trials as a collaborator. Other collaborators include 106 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Methodist Estabrook Cancer Center" are "Breast Cancer" (32 trials), "Lung Cancer" (22 trials), "Head and Neck Cancer" (16 trials), "Prostate Cancer" (15 trials) and "Brain and Central Nervous System Tumors" (13 trials). Many other conditions were trialed in "Methodist Estabrook Cancer Center" in a lesser frequency.

Most popular intervention types in "Methodist Estabrook Cancer Center" are "Drug" (162 trials), "Radiation" (73 trials), "Procedure" (38 trials), "Biological" (30 trials) and "Other" (19 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (48 trials), "cisplatin" (24 trials), "paclitaxel" (16 trials), "conventional surgery" (13 trials) and "Paclitaxel" (11 trials). Other intervention names were less common.

The vast majority of trials in "Methodist Estabrook Cancer Center" are 141 trials for "All" genders, 44 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Methodist Estabrook Cancer Center". undefined are not yet recruiting, 1 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 162 completed trials in Methodist Estabrook Cancer Center, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Methodist Estabrook Cancer Center, 13 "Phase 1" clinical trials were conducted, 94 "Phase 2" clinical trials and 89 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".